Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Robles Website

Ana I. Robles, Ph.D.

Selected Publications

1)  Robles AI, Harris CC.
A primate-specific microRNA enters the lung cancer landscape.
Proc. Natl. Acad. Sci. U.S.A. 110: 18748-9, 2013.
2)  Akagi I, Okayama H, Schetter AJ, Robles AI, Kohno T, Bowman ED, Kazandjian D, Welsh JA, Oue N, Saito M, Miyashita M, Uchida E, Takizawa T, Takenoshita S, Skaug V, Mollerup S, Haugen A, Yokota J, Harris CC.
Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma.
Cancer Res. 73: 3821-32, 2013.
3)  Ryan BM, Robles AI, Harris CC.
KRAS-LCS6 Genotype as a Prognostic Marker in Early-Stage CRC-Letter.
Clin. Cancer Res. 18: 3487-8, 2012.
4)  Robles AI, Harris CC.
Clinical outcomes and correlates of TP53 mutations and cancer.
Cold Spring Harb Perspect Biol. 2: a001016, 2010.
5)  Ryan BM, Robles AI, Harris CC.
Genetic variation in microRNA networks: the implications for cancer research.
Nat. Rev. Cancer. 10: 389-402, 2010.
6)  Pine SR, Ryan BM, Varticovski L, Robles AI, Harris CC.
Microenvironmental modulation of asymmetric cell division in human lung cancer cells.
Proc. Natl. Acad. Sci. U.S.A. 107: 2195-200, 2010.
7)  Robles AI, Linke SP, Harris CC.
The p53 network in lung carcinogenesis.
Oncogene. 21: 6898-907, 2002.
8)  Robles AI, Bemmels NA, Foraker AB, Harris CC.
APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis.
Cancer Res. 61: 6660-4, 2001.
9)  Robles AI, Rodriguez-Puebla ML, Glick AB, Trempus C, Hansen L, Sicinski P, Tennant RW, Weinberg RA, Yuspa SH, Conti CJ.
Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo.
Genes Dev. 12: 2469-74, 1998.
10)  Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Cancer Res. 56: 5391-6, 1996.
11)  Robles AI, Conti CJ.
Early overexpression of cyclin D1 protein in mouse skin carcinogenesis.
Carcinogenesis. 16: 781-6, 1995.
12)  Mitsunaga SI, Zhang SY, Ruggeri BA, Gimenez-Conti I, Robles AI, Conti CJ, Klein-Szanto AJ.
Positive immunohistochemical staining of p53 and cyclin D in advanced mouse skin tumors, but not in precancerous lesions produced by benzo[a]pyrene.
Carcinogenesis. 16: 1629-35, 1995.
13)  Filmus J, Robles AI, Shi W, Wong MJ, Colombo LL, Conti CJ.
Induction of cyclin D1 overexpression by activated ras.
Oncogene. 9: 3627-33, 1994.
14)  Robles AI, Gimenez-Conti IB, Roop D, Slaga TJ, Conti CJ.
Low frequency of codon 61 Ha-ras mutations and lack of keratin 13 expression in 7,12-dimethylbenz[a]-anthracene-induced hamster skin tumors.
Mol. Carcinog. 7: 94-8, 1993.
15)  Bianchi AB, Fischer SM, Robles AI, Rinchik EM, Conti CJ.
Overexpression of cyclin D1 in mouse skin carcinogenesis.
Oncogene. 8: 1127-33, 1993.
Click Here to View Collapsed Bibliography.

This page was last updated on 3/5/2014.